CorVel Corporation (CRVL -1.72%)
Q1 2021 Earnings Call
Aug 3, 2021, 11:30 a.m. ET
- Prepared Remarks
- Questions and Answers
- Call Participants
Thank you for standing by. Welcome to the CorVel Corporation Quarterly Earnings Release Webcast.
During the course of this webcast, CorVel Corporation may make projections or other forward-looking statements regarding future events with the future financial performances of the company. CorVel wishes to caution you that these statements are only predictions and the actual events or results may differ materially. CorVel refers you to the documents that the company files from time to time with the Securities and Exchange Commission, specifically the Company's last Form 10-K and 10-Q, files for the most recent fiscal year end quarter. These documents contain and identify important factors that could cause the actual results to differ materially from those contained in our projections or forward-looking statements.
I would now like to turn it over to Michael Combs, President and Chief Executive Officer.
10 stocks we like better than CorVel
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and CorVel wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of June 7, 2021
Michael Combs -- President & Chief Executive Officer
Good morning. Thank you for joining us to review CorVel's June Quarter. On the call with me today is Brandon O'Brien, CorVel's Chief Financial Officer. Today, we'll be discussing business performance, the current environment and market trends, and then move on to system development. Brendan will then provide an overview of our financial results for the June quarter.
Revenues for the quarter ended June 30, 2021 were $153 million. Earnings per share for the quarter were $0.92, increasing 102% from $0.46 per share in the same quarter of the prior year. The quarter-ending cash balance was $139 million, up $45 million from June 30, 2020. This increase is a proxy for the strength of our service model. It reflects the enhanced levels of automation and resulting efficiencies in our system, as well as the improvements to operations that have been accomplished and the dynamic environment during the pandemic.
The record revenue in the quarter ended June 30, 2021 is largely due to implementing and building on new business sold in 2020 and the first two quarters of this year, as well as an increase in transaction volumes as the year progressed. Prior to the June quarter, we experienced consecutive quarters of increased profit margins on relatively static revenues. In addition to increased investment in technology, we've expanded and enhanced our digital marketing strategy and engagement with various digital and print mediums. We're being more effective with marketing automation, content marketing, and brand activation.
After taking time during the past four earnings calls to discuss the pandemic and its impact on business, it's refreshing to talk about things settling into a new normal. With new accounts added, the resumption of medical procedures, increased claims, and bill [Phonetic] volume and demand for managed care, service lines are meeting or exceeding pre-pandemic levels. I recently had the privilege of visiting field offices where I was reminded of the resiliency and amazing accomplishments of our team during these last 18 months. In a quarter in which there are many things to be grateful for, I am most pleased with the exemplary work of our teams across the country.
The markets for all services strengthen through the quarter as the effects of the pandemic subsided. But as the economy restarts, the record number of unfulfilled jobs -- nine million -- presents a potential headwind in some sectors as carriers and others in the industry experienced resourcing difficulties, there will be increased appeal for alternative solutions to those functions, which have historically been handled in-house.
These market forces tend to increase demand for the risk management services that CorVel provides. With our robust foundation and proven results, we're well-positioned to address this increased need in the markets we serve. COVID-19 has been a catalyst for many in the workforce to assess what their new normal might be post-pandemic. The number of people considering career changes is rising. Many are questioning their role due to concerns about career advancement with their current employers.
Consistent with CorVel's designation as a great place to work, we have an established history of being a company where people can grow, advance and build a career -- something of which we're tremendously proud. The culture we've built in fostered is as important today as at any point in the company's history and we'll continue to invest in our associates and the environment at CorVel.
CorVel's new post-pandemic normal will include adjustments in our approach to physical offices -- some locations will transition from traditional work spaces to collaboration centers, ultimately reducing our overall carbon footprint. Office layouts will be modified to allow for additional meeting spaces and to enhance team collaboration. Space will be configured to support team members working full-time in the office, as well as those following the hybrid work model.
As always, we remain an organization focused upon improving healthcare experiences for the employees of our client customers. In the most recent quarters, efforts have been focused upon building our telehealth operations, strengthening and expanding the ability to integrate information across the various constituencies in an episode of care and adding sophisticated analytics tools to understand how best to improve outcomes. During the last year, we had the opportunity to better-define our highest development priorities in order to better-serve the patients in our program.
Automation and augmentation continue to be a focus for product development. Within our proprietary business systems, managing claims, managing cases, bill adjudication and ancillary services, millions of transactions occur each month. Within each area and for each operation, there are multiple steps and typically multiple people evolved in completing each unit of work.
Utilizing process mining tools, we are identifying those areas that will most benefit by the application of technology, specifically through automation. This is an effort that's iterative and ongoing. As we continue to make investments in existing foundational systems, the results will be increased capacity, quality and consistency with fewer exceptions.
We're employing multiple tools to augment the work of our claims professionals, nurse case managers and bill review analysts. Natural language processing is allowing us to zero in on and instill critical information from volumes of medical data. Machine learning, speech analytics and data mining are increasingly being used to identify claims that require additional attention and oversight. These technologies are also being used to identify fraud, waste and abuse.
One additional example of the practical application of technology is rules-based utilization review, which identifies treatment outside standards of care and alerts the appropriate stakeholders to take action. Early identification combined with systematic notification and intervention is resulting in improved outcomes for the injured workers, enhanced work flow for internal teams and reduce cost for our partners.
As we all know, the pandemic accelerated the acceptance of telehealth virtual care and other digital tools used by employers and employees. At CorVel, we've been building such services for several years and the receptivity created by the pandemic gave our efforts a nice boost. We're also starting to see adaption of peripheral devices in digital therapeutics to augment virtual visits. The integration of these technologies into virtual care increases patient engagement and results in improved health outcomes.
In the health market, wearable devices allow for comprehensive exams and diagnosis at home. The virtual diagnostic process is conducted completely by the patient. Data from peripheral and wearable devices when combined with pharmacy, medical claim and psychosocial data will continue to improve machine learning capabilities and the corresponding outcomes in workers' compensation.
In the health market, CERiS is capitalizing on the pandemic related advancement and hospital-specific electronic health records. The patient care gap is continuing to shrink among all parties. Electronic health records and related apps for medical documentation are becoming more and more accessible in real time.
Health systems currently have institutional solutions, but they are opening their systems to interact with the marketplace. Not only are we able to use digital information to ensure accuracy of documentation and payments, we're also able to administer payments directly to providers which insures continuous care. With CERiS' natural language processing capture, supported by artificial intelligence, coding is matched and affirmed or corrected prior to payment. The precision and speed of processing will only continue to increase as a technology advances.
Within CareMC Edge, our proprietary claims management platform, we have implemented a new program management interface for our carrier customers. This tool provides a high level view of program results and allows the user to benchmark their results against industry standards. The new interface also supports comparisons of different time intervals or subsections within the business.
We've also implemented a system which builds increasingly real time interfaces to improve the patient experience during an episode of care, supporting internal operations as well as our managed care partners. These features support additional data integration and security and allows users to operate within a single integrated system, streamlining the business work flow.
Symbeo, our revenue cycle management arm delivered an updated machine learning AI-assisted digital capture solution that provides a 75% reduction in overall processing time. The solution eliminates many of the inaccuracies with less automated solutions.
In the post-COVID environment where physical offices are shrinking, transitioning to digital revenue cycle management processes is increasingly important for our partners. Symbeo's products and services removed the need, in many cases, for customers to maintain mailrooms and reduces the overall effort our partners have historically spent on the individual stages in revenue cycle processing.
In addition to enhancements and additions in systems and services, we have an unrelenting focus on operational excellence. A working group of operational managers is dedicated to continuous improvement, ensuring performance is always at or above our established standards of service. Quality and outcomes are the hallmark of our services and we remain attentive to advancing results in this area. Brandon will now provide an overview and additional texture on the financial results for the June quarter.
Brandon O'Brien -- Chief Financial Officer
Thank you, Michael and good morning everyone. Revenues for the June quarter were a record $153 million, up 18% from the same quarter of the prior year. Earnings per share were a record $0.92, an increase of 102% from the $0.46 per share in the same quarter of the prior year. These results were made possible by the ongoing return of pre-pandemic market conditions for our existing customers plus the realized impact of robust new customer sales throughout the pandemic. The impact of new sales on revenue includes a healthy mix of services, ranging from existing customers expanding the breadth and depth of their services to establishing an entirely new customer relationship.
The profit generated during the quarter reflected improved operational efficiencies as the June quarter pre-tax operating margins increased from 8.4% in 2020 to a record 30.5% in 2021. The combination of the 18% increase of revenue with the increased margins provided the foundation for the year-over-year doubling of net income and EPS from the June quarter of 2020. Revenue for patient management, including third-party administration, TPA services and traditional case management for the June quarter was a record $100 million, an annual increase of 18%. Gross profit increased 24% from the June quarter of 2020.
Our third-party administration services hit record levels, leveraging increased market recognition and engagement of CorVel's enterprise comp. In fact CorVel's engagement percentage score on the prominent professional social media platform has trended upward and now leads our third-party administration industry peers. Revenue for Network Solutions sold in the wholesale market for the quarter was $52 million, up 18% from the same quarter of the prior year. Gross profit in the wholesale business was up 57% from the June quarter of 2020. Gross margins increased due to an improving business mix within both the workers' compensation and health wholesale markets. The average size of the medical bill review increased providing additional opportunities for our Medical cost containment services to be applied. This translates to increased recommended savings for our customers producing higher Network Solutions revenue.
I would now like to review a few additional financial items. During the quarter, the company repurchased 118893 shares at a total cost of $14.2 million. From inception to-date, the company has repurchased 36.8 million shares for a total cost of $579 million. Through this program, the company has repurchased 67% of the total shares outstanding. The repurchasing our shares continues to be exclusively funded via the company's strong operating cash flow. The quarterly cash flow speaks to the strength of our service model, including increased levels of automation, with the resulting efficiencies plus improvements to operations that have been accomplished in the changing environment during the pandemic.
Annualized return on net invested assets for the quarter was a very strong 81%. Return on total equity has been consistently 20% or more every year. The quarter ending cash balance was $139 million. Our DSO as in days sales outstanding and receivables, was 40 days, down 7 days from a year ago.
That concludes our remarks for today. Thank you for joining us. I'll now return the call to our operator.
[Operator Closing Remarks]
Questions and Answers:
Duration: 17 minutes
Michael Combs -- President & Chief Executive Officer
Brandon O'Brien -- Chief Financial Officer